Tyra Biosciences, Inc.

Todd Harris (President and CEO) reports TYRA insider transactions

4TYRAFiled Sep 17, 2026, 3:29 PM ET· Period Sep 15, 2026

About this filing

Tyra Biosciences, Inc. (TYRA) filed Form 4 (insider transaction) with the SEC on Sep 17, 2026. Form 4 reports a company insider’s trades in the company’s shares.

View original filing on SEC.gov

Key facts

Insider: Todd Harris · President and CEO, Director

Date	Transaction	Shares	Price	Value	Held after	Ownership
Sep 15, 2026	A · grantFootnotes F1, F2	+864	$9.13	$7,887.46	1,438,495	Direct

Footnotes

F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
F2 Includes restricted stock units.

More TYRA filings

SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Oct 27, 2026
SC 13G
Ownership over 5% (passive)
Filed Sep 21, 2026
4
Insider transaction
Filed Sep 17, 2026
4
Insider transaction
Filed Sep 17, 2026
SC 13D/A
Ownership over 5% (active) (amendment)
Filed Sep 17, 2026
4
Insider transaction
Filed Sep 17, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.